3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Gemcitabine
26
Specimen Handling
20
130-nm albumin-bound paclitaxel
18
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Biopsy
12
Fluorouracil
11
Leucovorin
10
Oxaliplatin
9
Cyclophosphamide
8
pembrolizumab
7
fludarabine
7
Albumin-Bound Paclitaxel
7
Cisplatin
6
Cetuximab
6
Nivolumab
5
durvalumab
4
Taxes
4
Radiosurgery
4
Pemetrexed
4
Capecitabine
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
dehydroftorafur
3
aldesleukin
3
Radiotherapy
3
Immunoglobulin G
3
Exercise
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.